Melbourne, Apr 23, 2020 (Issuewire.com) - Research fund with $500,000 urgently calls for Australian COVID-19 science projects
Eureka Technology Innovation and Investment (Eureka TechIN) is inviting Australian scientists to apply for a share of an AU$500,000 research fund in order to boost COVID-19 efforts.
Headquartered in Melbourne, Australia Eureka TechIN has launched the Eureka Research Fund for Immunology and Virology and will close applications at 5 pm Sunday, April 26.
The initial commitment of AU$500,000 will support Australian scientific research activities which focus on anti-virus research. The research can be focused on developing new COVID-19 testing methods, finding a prevention or cure, or related technology for this devastating virus.
The fund also comes with a team of business and manufacturing specialists who will collaboratively work with and support the scientists to get their discoveries out into the community as quickly as possible.
"Eureka TechIN is providing a fast track to Australian science with the announcement of this fund. We will provide scientists with the funds they need to collaborate on a shared goal. Then, we access the best business and manufacturing expertise to cooperatively bring their discoveries out into the community.
"With the rapid development of COVID-19, we want to create a network of the brightest Australian minds, all sharing expertise and resources to address this critical global issue," said Dr. Ruchong Ou, member of Eureka TechIN Advisory Board and Senior Research Fellow, Monash University and Alfred Hospital.
"Australian scientists are among the best in the world and with this grant they can hire the right personnel to establish a new joint research project with other scientists," said Dr. Ruchong Ou.
The Eureka Research Fund for Immunology and Virology will be managed by Eureka TechIN throughout the process from application review, monitoring and evaluation. Eureka TechIN has an esteemed Advisory Board to assist with fund management and to ensure a high quality of research is delivered.
The Eureka TechIN Advisory Board includes:
- Ruchong Ou
- Senior Research Fellow, Monash University and Alfred Hospital
- Director of the Board, Australia China Health Accelerator
- Chairman of the Board, Oculus Biomed Pty. Ltd.
- Assoc Prof. David Anderson
- Deputy Director, Burnet Institute
- Head, Global Health Diagnostics Development, Burnet Institute
- Founder and CEO, Nanjing BioPoint Diagnostics
- Paul Hertzog
- Head of the Centre for Immunity and Infectious Diseases
- Associate Director of the Hudson Institute of Medical Research
- Co-Founder of the Victorian Infection and Immunity Network
"This fund will support critical research projects of Australian scientists and importantly, gives them access to business partners who can deliver their discoveries to the community for positive impact," said Michelle Xu, General Manager of Eureka TechIN.
The AU$500,000 Eureka Research Fund for Immunology and Virology is open to Australian researchers and scientists.
Those interested in applying for the grant can apply today and until 5 pm Sunday, April 26 at https://www.eurekatechin.com.au.
For media enquiries, contact:
Kristen Boschma
How Communications
M: 0421 63 87 92
BACKGROUND NOTES
About Eureka TechIN
Established in 2017, Eureka TechIN is headquartered in Melbourne.
Eureka TechIN builds a platform that fosters science and technology innovation by connecting experts, funding bodies and partners.
Eureka TechIN brings together experts who focus their efforts on creating value for Australian small and medium-sized enterprises. With global networks across the Asia Pacific, Europe and Northern America, Eureka TechIN has the capability to fund, lead and facilitate technology innovation for Australian research and businesses.
Eureka TechIN is collaborating with the wider Eureka Health Group and this creates further opportunities. Eureka Health Group integrates Australian high-end medical resources to deliver "Science and technology-led medical care and services for the local market".
The Eureka Research Fund for Immunology and Virology, announced by Eureka TechIN, will support 3 fields of research:
- Anti-virus and anti-bacteria,
- Immunity,
- Stem cell.
With the rapid development of COVID-19 virus, the call for the first round of applications will be focused on anti-virus research.
Applications can be made until 5pm Sunday April 26 at: https://www.eurekatechin.com.au
Media Contact
How Communications
0421 63 87 92
Melbourne
Source :Eureka TechIN
This article was originally published by IssueWire. Read the original article here.
